Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3102 ARTÍCULOS , VIENDO DEL 1021 AL 1035

[Metric properties of clinimetric indexes for non-motor dysfunction of Parkinson's disease in Mexican population]

Cervantes-Arriaga A, Rodríguez-Violante M, Villar-Velarde A, López-Gómez M, Corona T.

Rev Invest Clin. 2010 Jan-Feb;62(1):8-14.

Effectiveness of aripiprazole in a patient with presumed idiopathic Parkinson's disease and chronic paranoid schizophrenia

Fujino J, Tanaka H, Taniguchi N, Tabushi K.

Psychiatry Clin Neurosci. 2010 Feb;64(1):108-9. doi: 10.1111/j.1440-1819.2009.02050.x.

Gender-specific role of mitochondria in the vulnerability of 6-hydroxydopamine-treated mesencephalic neurons

Misiak M, Beyer C, Arnold S.

Biochim Biophys Acta. 2010 Jun-Jul;1797(6-7):1178-88. doi: 10.1016/j.bbabio.2010.04.009. Epub 2010 Apr 20.

Pluripotent stem cells in neurodegenerative and neurodevelopmental diseases

Marchetto MC, Winner B, Gage FH.

Hum Mol Genet. 2010 Apr 15;19(R1):R71-6. doi: 10.1093/hmg/ddq159. Epub 2010 Apr 23.

Genetic determinants at the interface of cancer and neurodegenerative disease

Morris LG, Veeriah S, Chan TA.

Oncogene. 2010 Jun 17;29(24):3453-64. doi: 10.1038/onc.2010.127. Epub 2010 Apr 26.

How does the brain create rhythms?

Szirmai I.

Ideggyogy Sz. 2010 Jan 30;63(1-2):13-23.

Parkinson's disease: insights from pathways

Cookson MR, Bandmann O.

Hum Mol Genet. 2010 Apr 15;19(R1):R21-7. doi: 10.1093/hmg/ddq167. Epub 2010 Apr 26.

[Deep brain stimulation for Parkinson's disease]

Herzog J, Deuschl G.

Nervenarzt. 2010 Jun;81(6):669-79. doi: 10.1007/s00115-010-2938-3.

[Treatment of mental disorders in patients with Parkinson's disease]

Meincke U, Kosinski CM.

Fortschr Neurol Psychiatr. 2010 May;78(5):279-87. doi: 10.1055/s-0029-1245307. Epub 2010 Apr 26.

Membrane interactions of oligomeric alpha-synuclein: potential role in Parkinson's disease

van Rooijen BD, Claessens MM, Subramaniam V.

Curr Protein Pept Sci. 2010 Aug;11(5):334-42. doi: 10.2174/138920310791330659.

The role of neuroinflammation on the pathogenesis of Parkinson's disease

Chung YC, Ko HW, Bok E, Park ES, Huh SH, Nam JH, Jin BK.

BMB Rep. 2010 Apr;43(4):225-32. doi: 10.5483/bmbrep.2010.43.4.225.

Biochemical and molecular features of LRRK2 and its pathophysiological roles in Parkinson's disease

Seol W.

BMB Rep. 2010 Apr;43(4):233-44. doi: 10.5483/bmbrep.2010.43.4.233.

Studies of Chinese speakers with dysarthria: informing theoretical models

Whitehill TL.

Folia Phoniatr Logop. 2010;62(3):92-6. doi: 10.1159/000287206. Epub 2010 Apr 29.

Short-term effects of repetitive transcranial magnetic stimulation on speech and voice in individuals with Parkinson's disease

Hartelius L, Svantesson P, Hedlund A, Holmberg B, Revesz D, Thorlin T.

Folia Phoniatr Logop. 2010;62(3):104-9. doi: 10.1159/000287208. Epub 2010 Apr 29.

Gout, hyperuricemia, and Parkinson's disease: a protective effect?

Alonso A, Sovell KA.

Curr Rheumatol Rep. 2010 Apr;12(2):149-55. doi: 10.1007/s11926-010-0083-4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias